INTS vs PNR · $7.7M cap vs P/E 18, rev $4.08B
Intensity Therapeutics, Inc. Common stock (INTS) versus Pentair PLC (PNR) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Pentair PLC (PNR) is a specialty industrial machinery company listed on NYSE.
INTS does not have a complete income-statement cache yet.
Latest reported PNR revenue for 2024-12-31 was $4.08B. Net income was $625.4M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
INTS currently screens at market cap $7.7M. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
Not investment advice. Open the INTS and PNR stock pages for the full models.
Not investment advice.